
Lemtrada 12mg Infusion
Marketer
Sanofi India Ltd
Salt Composition
Alemtuzumab (12mg)
Overview Lemtrada 12mg Infusion
Alembic's Lemtrada (12mg infusion) treats chronic lymphocytic leukemia and multiple sclerosis. It targets cancerous cells for immune system elimination and modifies immune responses to reduce nervous system damage. Administered under medical supervision, dosage and frequency are individualized based on your condition and may adjust over time. Strictly adhere to your doctor's instructions; incorrect usage can lead to severe complications. Therapeutic effects might take weeks or months; discontinue only with your physician's approval. Common side effects include rash, headache, and sleep disturbances. The medication can lower white blood cell counts, increasing infection and bleeding risks. Report fever, chills, cough, mouth sores, breathing difficulties, unusual bleeding or bruising, or blood in urine immediately. Post-infusion monitoring is crucial due to potential life-threatening reactions like chest pain, shortness of breath, and irregular heartbeat. Inform your doctor of pre-existing heart, liver, or kidney conditions, and all other medications (including infection treatments) before commencing treatment, as interactions are possible. Avoid pregnancy during treatment; effective contraception for both partners is essential.
Uses of Lemtrada 12mg Infusion
Chronic lymphocytic leukemia and multiple sclerosis
Major Benefits of Lemtrada 12mg Infusion:
This medication will be administered by your healthcare provider. Self-medication is not advised.
Common Side effects of Lemtrada 12mg Infusion:
- Rash
- Headache
- Insomnia (difficulty in sleeping)
- Nausea
- Upper respiratory tract infection
- Decreased white blood cell count
- Fatigue
- Fever
- Itching
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Hives
- Decreased white blood cell count (lymphocytes)
How to use Lemtrada 12mg Infusion:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Lemtrada 12mg Infusion works:
Lemtrada, a 12mg infusion, is a targeted monoclonal antibody therapy. This treatment identifies cancerous cells, marking them for elimination by the patient's own immune defenses. Simultaneously, it regulates immune system activity to prevent harm to the nervous system.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Lemtrada 12mg Infusion may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Lemtrada 12mg Infusion during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Lemtrada 12mg Infusion while breastfeeding is likely inadvisable. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Treatment with Lemtrada 12mg infusion can lead to reduced alertness, visual disturbances, drowsiness, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding Lemtrada 12mg infusion use in patients exhibiting renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding Lemtrada 12mg Infusion use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Lemtrada 12mg Infusion :
Forgetting a scheduled Lemtrada 12mg infusion requires immediate physician consultation.
Facts to Know About Lemtrada 12mg Infusion
| Label | Value |
|---|---|
| Chemical Category | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Cancer Drugs |
| Action Class | Anti-CD52 Therapies |
